Purchases and Sales Made in Q1 2025 in Adc Therapeutics Sa (ADCT)
This table provides information about the institutional ownership of Adc Therapeutics Sa (ADCT) during Q1 2025. The information is specifically focused on institutions that hold shares of ADC Therapeutics SA.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
Barclays PLC
London, X0 |
SELL
|
- |
-40.5K- 28.6% |
$56.2K - $81.7K
|
101K
$273K
|
|
|
May 09, 2025
Q1 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-90.1K- 5.38% |
$125K - $182K
|
1.58M
$4.27M
|
|
|
May 13, 2025
Q1 2025
|
Ubs Group Ag
|
SELL
|
- |
-117K- 13.28% |
$163K - $237K
|
767K
$2.07M
|
|
|
May 15, 2025
Q1 2025
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-139K- 75.61% |
$193K - $280K
|
44.7K
$121K
|
|
|
May 15, 2025
Q1 2025
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-246K- 59.91% |
$342K - $498K
|
165K
$445K
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-937K- 23.67% |
$1.3M - $1.89M
|
3.02M
$8.15M
|
|
|
May 15, 2025
Q1 2025
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-1.12M- 57.83% |
$1.55M - $2.26M
|
816K
$2.2M
|